Does vascepa's impact on heart health last beyond prescription?

Short answer: The cardiovascular benefit seen with Vascepa (icosapent ethyl) is tied to ongoing therapy. There isn’t strong evidence of a lasting “legacy” benefit after stopping the medicine, and once you stop, any reductions in triglycerides and related heart-protective effects tend to wane over time.

A few things to keep in mind:
- What Vascepa does: It lowers triglycerides and has been shown to reduce major cardiovascular events when added to statin therapy in high-risk adults (as shown in the REDUCE-IT trial).
- Durability of benefit: The trial’s benefits were observed while patients continued Vascepa. There isn’t robust data showing a meaningful, lasting CV benefit after stopping the drug.
- What happens after stopping: Triglyceride levels often rise again toward baseline after discontinuation, and the associated risk reduction is unlikely to persist if you’re not taking the medicine.
- Side effects and decisions: If cost, side effects, or other concerns are driving you toward stopping, talk with your doctor. They can discuss options (dose adjustments, alternative therapies, or lifestyle changes) to maintain heart health.

If you’d like, tell me why you’re asking (side effects, cost, or something else) and I can tailor the guidance or help you prepare questions for your clinician.